[替拉瑞韦、聚乙二醇干扰素α-2b与利巴韦林联合治疗基因2型慢性丙型肝炎难治性患者] - Suppr | 超能文献

[Telaprevir, PEG-IFNα-2b and ribavirin combination therapy for difficult to treat patients with genotype 2 chronic hepatitis C].

作者信息

Nishimura Takeshi

出版信息

Nihon Rinsho. 2015 Dec;73 Suppl 9:193-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Telaprevir, PEG-IFNα-2b and ribavirin combination therapy for difficult to treat patients with genotype 2 chronic hepatitis C].[替拉瑞韦、聚乙二醇干扰素α-2b与利巴韦林联合治疗基因2型慢性丙型肝炎难治性患者]

Nihon Rinsho. 2015 Dec;73 Suppl 9:193-8.

2

Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.特拉匹韦单药或与聚乙二醇干扰素和利巴韦林联合治疗可降低慢性基因型 2 但不能降低基因型 3 感染患者的 HCV RNA。

Gastroenterology. 2011 Sep;141(3):881-889.e1. doi: 10.1053/j.gastro.2011.05.046. Epub 2011 May 31.

3

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure.西米普明三联疗法对既往特拉匹韦治疗失败的慢性丙型肝炎1b型患者的疗效。

J Viral Hepat. 2015 Dec;22(12):992-1001. doi: 10.1111/jvh.12427. Epub 2015 Jun 15.

4

[Chronic hepatitis C: improved cure rates with new approved medications].[慢性丙型肝炎：新型获批药物提高治愈率]

MMW Fortschr Med. 2012 Jun 21;O 154 Suppl 2:65-9; quiz 70. doi: 10.1007/s15006-012-0771-2.

5

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1.替拉瑞韦剂量对HCV基因1型慢性丙型肝炎患者接受替拉瑞韦、聚乙二醇干扰素和利巴韦林治疗的抗病毒效果及副作用的实际影响。

J Viral Hepat. 2015 Mar;22(3):254-62. doi: 10.1111/jvh.12289. Epub 2014 Jul 31.

6

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.每日两次特拉匹韦与每 8 小时一次特拉匹韦治疗慢性丙型肝炎患者的疗效相当。

Gastroenterology. 2014 Mar;146(3):744-753.e3. doi: 10.1053/j.gastro.2013.11.047. Epub 2013 Dec 4.

7

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.特拉匹韦与聚乙二醇干扰素联合或不联合利巴韦林用于慢性丙型肝炎病毒感染的治疗。

N Engl J Med. 2009 Apr 30;360(18):1839-50. doi: 10.1056/NEJMoa0807650.

8

Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.聚乙二醇干扰素α-2a（40KD）联合利巴韦林治疗日本慢性丙型肝炎患者。

J Gastroenterol Hepatol. 2007 May;22(5):645-52. doi: 10.1111/j.1440-1746.2007.04834.x.

9

Pegylated interferon and ribavirin: A therapeutic option in patients who fail to respond to telaprevir-based triple therapy?聚乙二醇化干扰素和利巴韦林：对基于特拉匹韦的三联疗法无反应的患者的一种治疗选择？

Hepatology. 2013 Aug;58(2):828. doi: 10.1002/hep.26247.

10

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.特拉匹韦联合聚乙二醇干扰素和利巴韦林用于慢性丙型肝炎1型感染

N Engl J Med. 2009 Apr 30;360(18):1827-38. doi: 10.1056/NEJMoa0806104.